Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Cytomegalovirus (CMV) remains an important cause of morbidity and mortality after allogeneic stem cell transplantation (SCT), but cytotoxic T lymphocytes (CTL) may play a critical role in controlling CMV reactivation. Fluorescent HLA-peptide tetramers containing immunodominant peptides from CMV were used to prospectively monitor the recovery of CMV CTL in recipients of allogeneic transplants from siblings (n = 13) or unrelated donors (n = 11). In patients given allografts from a sibling when both the patient and donor were seropositive for CMV before SCT, recovery of CMV-specific CTL was rapid and reached up to 21% of all CD8+ T cells. Early reconstitution of CMV-specific immunity was not observed if either the donor or recipient was seronegative for CMV. In recipients of transplants from volunteer unrelated donors, recovery of CMV-specific CTL was delayed in comparison to that in recipients of transplants from siblings and no CTL were observed within the first 100 days after SCT. CTL numbers were increased after episodes of CMV reactivation but were suppressed by prednisolone therapy. Recovery of CMV-specific CTL to levels greater than 10 × 106/L was associated with protection from CMV disease. It was concluded that use of HLA-peptide tetramers to quantify CMV CTL is valuable for studying T-cell responses after allogeneic SCT. It should allow prediction of CMV reactivation in individual patients and assist in the development of adoptive T-cell immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GLUCKSBERG, H., STORB, R., FEFER, A., BUCKNER, C. D., NEIMAN, P. E., CLIFT, R. A., LERNER, K. G., & THOMAS, E. D. (1974) · Transplantation · doi:10.1097/00007890-197410000-00001 · Cited by 3,694
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“5 3 109/L 25 (14-33) 26 (13-35) Platelets .”
Self-citationCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., & Riddell, S. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331603 · Cited by 1,771
Storb, R., Deeg, H. J., Whitehead, J., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C. D., Clift, R., Doney, K., Farewell, V., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383
Phenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366
Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E., & Greenberg, P. D. (1992) · Science · doi:10.1126/science.1352912 · Cited by 1,201
Risk Factors for Cytomegalovirus Infection after Human Marrow Transplantation
Meyers, J. D., Flournoy, N., & Donnall Thomas, E. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/153.3.478 · Cited by 776
Trowbridge, I. S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.85 · Cited by 755
Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant
Goodrich, J. M., Bowden, R. A., Fisher, L., Keller, C., Schoch, G., & Meyers†, J. D. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00003 · Cited by 650
Boeckh, M., Gooley, T., Myerson, D., Cunningham, T., Schoch, G., & Bowden, R. (1996) · Blood · doi:10.1182/blood.v88.10.4063.bloodjournal88104063 · Cited by 646
A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers
Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O’Callaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B., & Callan, M. F. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1827 · Cited by 499
Li, C., Greenberg, P., Gilbert, M., Goodrich, J., & Riddell, Sr. (1994) · Blood · doi:10.1182/blood.v83.7.1971.1971 · Cited by 494
Gillespie, G. M. A., Wills, M. R., Appay, V., O'Callaghan, C., Murphy, M., Smith, N., Sissons, P., Rowland-Jones, S., Bell, J. I., & Moss, P. A. H. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8140-8150.2000 · Cited by 420
Self-citationPolić, B., Hengel, H., Krmpotić, A., Trgovcich, J., Pavić, I., Lučin, P., Jonjić, S., & Koszinowski, U. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1047 · Cited by 361
Broers, A. E. C., van der Holt, R., van Esser, J. W. J., Gratama, J.-W., Henzen-Logmans, S., Kuenen-Boumeester, V., Löwenberg, B., & Cornelissen, J. J. (2000) · Blood · doi:10.1182/blood.v95.7.2240 · Cited by 348
Heitger, A., Neu, N., Kern, H., Panzer-Grümayer, E.-R., Greinix, H., Nachbaur, D., Niederwieser, D., & Fink, F. M. (1997) · Blood · doi:10.1182/blood.v90.2.850 · Cited by 198
Wilson, A., Sharp, M., Koropchak, C. M., Ting, S. F., & Arvin, A. M. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.1.119 · Cited by 192
Gor, D., Sabin, C., Prentice, H., Vyas, N., Man, S., Griffiths, P., & Emery, V. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701139 · Cited by 180
Ljungman, P., Aschan, J., Lewensohn-Fuchs, I., Carlens, S., Larsson, K., L??nnqvist, B., Mattsson, J., Sparrelid, E., Winiarski, J., & Ringd??n, O. (1998) · Transplantation · doi:10.1097/00007890-199811270-00012 · Cited by 176
Wills, M. R., Carmichael, A. J., Weekes, M. P., Mynard, K., Okecha, G., Hicks, R., & Sissons, J. G. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7080 · Cited by 167
Krause, H., Hebart, H., Jahn, G., Müller, C., & Einsele, H. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700801 · Cited by 163
CYTOMEGALOVIRUS PNEUMONIA AFTER BONE MARROW TRANSPLANTATION
FACTORS, R., Haake, R. J., Weisdorf, D. J., Ramsay, N. K. C., McGlave, P. B., Kersey, J., Thomas, W. J., MCKENZIE, D., & Miller, W. J. (1993) · Transplantation · doi:10.1097/00007890-199306000-00024 · Cited by 156
Boeckh, M., Gallez-Hawkins, G. M., Myerson, D., Zaia, J. A., & Bowden, R. A. (1997) · Transplantation · doi:10.1097/00007890-199707150-00020 · Cited by 150
Engstrand, M., Tournay, C., Peyrat, M. A., Eriksson, B., Wadström, J., Wirgart, B. Z., Romagn, F., Bonneville, M., tterman, T. H. T., & Korsgren, O. (2000) · Transplantation · doi:10.1097/00007890-200006150-00005 · Cited by 88
Dolstra, H., Preijers, F. W. M. B., Kemenade, E. V. D. W.-V., Schattenberg, A., Galama, J. M. D., & de Witte, T. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05150.x · Cited by 70
Arlettaz, L., Barbey, C., Dumont-Girard, F., Helg, C., Chapuis, B., Roux, E., & Roosnek, E. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199912)29:12<3987::aid-immu3987>3.0.co;2-4 · Cited by 68
Spencer, A. G., Brookes, P., KAMINSKI, E., Hows, J., Szydlo, R., van Rhee, F., Goldman, J. M., & Batchelor, J. R. (1995) · Transplantation · doi:10.1097/00007890-199505000-00014 · Cited by 59
Self-citationSinghal, S., Shaw, J. C., Ainsworth, J., Hathaway, M., Gillespie, G. M. A., Paris, H., Ward, K., Pillay, D., Moss, P. A. H., & Mutimer, D. J. (2000) · Transplantation · doi:10.1097/00007890-200006150-00006 · Cited by 58
Self-citation
Cited by
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Boeckh, M., Leisenring, W., Riddell, S. R., Bowden, R. A., Huang, M.-L., Myerson, D., Stevens-Ayers, T., Flowers, M. E. D., Cunningham, T., & Corey, L. (2003) · Blood · doi:10.1182/blood-2002-03-0993 · Cited by 598
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
Gandhi, M. K., & Khanna, R. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01202-2 · Cited by 563
Cruz, C. R. Y., Micklethwaite, K. P., Savoldo, B., Ramos, C. A., Lam, S., Ku, S., Diouf, O., Liu, E., Barrett, A. J., Ito, S., et al. (2013) · Blood · doi:10.1182/blood-2013-06-506741 · Cited by 508
Cobbold, M., Khan, N., Pourgheysari, B., Tauro, S., McDonald, D., Osman, H., Assenmacher, M., Billingham, L., Steward, C., Crawley, C., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040613 · Cited by 480
“Endogenous CMV-specific immune reconstitution can be brisk in patients with sibling donors, but transplants from unrelated donors are associated with markedly impaired reconstitution within the first 100 d (8, 15).”
BackgroundSelf-citation
Metadata
- Authors
- Cwynarski, K., Ainsworth, J., Cobbold, M., Wagner, S., Mahendra, P., Apperley, J., Goldman, J., Craddock, C., & Moss, P. A. H.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2001-03-01
- Volume
- 97
- Issue
- 5
- Pages
- 1232-1240
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2073493139
- Cited by
- 292
- References
- 30
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.